Clinical Proteomics

News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.

Jun 13, 2022

OncoHost Licenses SomaLogic Platform to Develop Tests to Predict Patient Response to Immunotherapies

Jun 2, 2022

InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma
Premium

Jun 1, 2022

BioMérieux Invests €2M in French Sepsis Dx Startup Weezion

May 13, 2022

SomaLogic Plans New Data Products, Licensing and Test Development Agreements
Premium

Mar 30, 2022

SomaLogic Previews New Products, Global Expansion Coming in 2022
Premium

Mar 18, 2022

BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System

Jul 14, 2021

Sera Prognostics Goes Public With $75M IPO

Jun 3, 2021

UC Davis Researchers Developing Direct-to-MALDI COVID-19 Screening Test
Premium

Apr 29, 2021

Sera Prognostics Raises $100M in Series E Round

Mar 16, 2021

Stella Dx, University of Kansas Medical Center Collaborate on Barrett's Esophagus Panel

Nov 17, 2020

NanoString Technologies, OHSU Partner on Breast Cancer Spatial Protein Profiling Assay Development

Aug 11, 2020

RenalytixAI, Academic Partners to Monitor Chronic Kidney Disease in Recovered COVID-19 Patients

Jul 10, 2020

NEC Company Collaborating With Somalogic on Proteomics-Based Health Monitoring

Dec 27, 2019

Oncology Test Development Grabs Lion's Share of Diagnostics Investments in 2019
Premium

Dec 9, 2019

StageZero, Oncore Pharma Expand Test Deal

Oct 24, 2019

Calviri to Develop Checkpoint Inhibitor Response Prediction Test Under $300K NCI Grant

Sep 25, 2019

With C. Auris Proliferating, NYSDOH Wadsworth Center to Fund Device Development for POC Tests
Premium

Sep 18, 2019

Oncimmune Scottish Study Results Could Fuel Move Into Screening as Firm Eyes CDx Opportunities
Premium

Sep 17, 2019

SomaLogic Enters Clinic With Launch of First Test Based on SomaScan Platform
Premium

Aug 26, 2019

Japanese Firm Atonarp Closes $33M Series C Round